Outpace Bio
Latest round
- Series B
Last raised
- Jul 2024
Total raised
- $81M
Investors
- 17
About Outpace Bio
Outpace Bio, Inc.Founded in 2020, Outpace Bio, Inc. focuses on developing innovative treatments for cancer through engineered cell therapies.Outpace Bio, Inc. specializes in innovative cell therapy solutions that leverage advanced protein design technologies to enhance the efficacy and safety of cancer treatments. Their primary offerings include the OUTSMART™, OUTLAST™, OUTSPACER™, OUTSAFE™, and CO-LOCKR™ technologies, which work collaboratively to address the critical challenges faced in solid tumor treatment. By programming engineered cells to recognize and eliminate cancer while navigating the complexities of the tumor microenvironment, these products collectively aim to improve immune response, enhance cell therapy persistence, and provide precise targeting of cancer cells.Outpace Bio generates revenue through partnerships and collaborations with biopharmaceutical firms and academic institutions that seek to harness their advanced cell therapy technologies. The company engages in B2B transactional structures, allowing clients to access their proprietary technologies through licensing agreements or collaborative research initiatives.On July 17, 2024, Outpace Bio, Inc. Specific new products are expected to be developed, although release dates have not been disclosed.
Who invested in Outpace Bio
17 investors across 2 rounds
See all investors in Outpace Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Outpace Bio
Who invested in Outpace Bio?
Outpace Bio has 17 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Outpace Bio raised?
Outpace Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Outpace Bio last raise money?
Outpace Bio's most recent round on record is a Series B, in Jul 2024.
What does Outpace Bio do?
Outpace Bio is a biotechnology company.
Where is Outpace Bio headquartered?
Outpace Bio is headquartered in Seattle, US.
Which VCs invest in companies like Outpace Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Outpace Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Outpace Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.